Inhibikase Therapeutics, Inc.
IKT
Revenue
0.00
0.000.00%
3 Months ChangeAssets
8.83M
▼-2.24M▼-20.25%
3 Months ChangeLiabilities
3.73M
▼-561.30k▼-13.08%
3 Months ChangeFree Cash Flow
-18.10M
▼-504.92k▼-2.87%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001193125-24-240603
2024-10-10
Form 8-K
ID: 0001193125-24-236039
2024-10-09
Form 8-K
ID: 0001193125-24-234814
2024-08-14
Form 10-Q
ID: 0000950170-24-097022
2024-08-06
Form 8-K
ID: 0001193125-24-194177
2024-06-10
Form 8-K
ID: 0001193125-24-158318
2024-05-20
Form 8-K
ID: 0001193125-24-142317
2024-05-15
Form 10-Q
ID: 0000950170-24-060579
2024-04-30
Form 8-K
ID: 0001193125-24-123758
2024-04-19
Form 8-K
ID: 0001193125-24-101292